Actively Recruiting
Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Led by Samsung Medical Center · Updated on 2025-03-14
200
Participants Needed
1
Research Sites
761 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.
CONDITIONS
Official Title
Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject over age of 18
- Patients received heart transplant
You will not qualify if you...
- Patients with cardiogenic shock
- Patients with unstable vital sign that precludes coronary angiography
- Patients with major bleeding in last 3 months
- Patients with active bleeding
- Patients with coagulopathy
- Patients with severe valvular heart disease
- Patients who refused to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
J
Joo Myung Lee, MD, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here